Novartis and DNDi to jointly develop a new oral drug to treat visceral leishmaniasis EurekAlert Post navigation New wearable sensor could help remotely detect critical changes in heart failure patients – News-Medical.net ‘Stigma, shame and frustration’: cashless welfare card found to do more harm than good – The Guardian